Principal Financial Group’s Arbutus Biopharma ABUS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.4K	Buy	+10,977	New	+$48K	﹤0.01%	2152
2025 Q4	–	Sell	-11,859	Closed	-$53.8K	–	2183
2025 Q3	$53.8K	Buy	11,859 +1,051	+10%	+$3.86K	﹤0.01%	2211
2025 Q2	$33.4K	Sell	10,808 -720	-6%	-$2.39K	﹤0.01%	2203
2025 Q1	$40.2K	Sell	11,528 -1,288	-10%	-$4.29K	﹤0.01%	2128
2024 Q4	$41.9K	Sell	12,816 -939	-7%	-$3.45K	﹤0.01%	2175
2024 Q3	$53K	Sell	13,755 -12,352	-47%	-$47.4K	﹤0.01%	2174
2024 Q2	$80.7K	Sell	26,107 -15,341	-37%	-$46K	﹤0.01%	2240
2024 Q1	$107K	Sell	41,448 -4,127	-9%	-$10.7K	﹤0.01%	2266
2023 Q4	$114K	Sell	45,575 -25	-0.1%	-$49	﹤0.01%	2251
2023 Q3	$92.6K	Buy	45,600 +3,915	+9%	+$8.21K	﹤0.01%	2294
2023 Q2	$95.9K	Buy	41,685 +2,603	+7%	+$6.78K	﹤0.01%	2296
2023 Q1	$118K	Buy	39,082 +251	+0.6%	+$708	﹤0.01%	2277
2022 Q4	$90.5K	Buy	38,831 +24,800	+177%	+$59.3K	﹤0.01%	2308
2022 Q3	$27K	Buy	14,031 +2,191	+19%	+$5.16K	﹤0.01%	2443
2022 Q2	$32K	Buy	+11,840	New	+$30.3K	﹤0.01%	2481